Literature DB >> 6997213

Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli.

G Källenius, R Möllby, S B Svenson, J Winberg, H Hultberg.   

Abstract

Earlier investigations have shown that pyelonephritic Escherichia coli specifically recognize and bind to carbohydrate structures correlated to the P blood group antigens. These findings are confirmed and extended in this study. Twenty-two of 23 nonselected E. coli strains from children with acute febrile pyelonephritis failed to agglutinate human erythrocytes lacking the antigens within the P blood group system. Only one of 32 faecal isolates exhibited this specific agglutinating property. The new informatin in this paper is that P2k erythrocytes, containing only the Pk antigen, were agglutinated to the same extent by pyelonephritic E. coli strains, giving further support to the proposal that the Pk glycosphingolipid is related to the receptor for pyelonephritic E. coli. In addition, the importance of the oligosaccharide moiety of the Pk glycosphingolipid for the binding of E. coli was further investigated. The synthesized disaccharide alpha-D-Galp-(1-4)-beta-D-Galp-1-O-0-NO2 inhibited the agglutination of human erythrocytes caused by two pyelonephritic E. coli strains at concentrations of less than 1 mM. Hence, the minimal receptor structure recognized by these E. coli strains appears to be the alpha-D-Galp-(1-4)-beta-D-Galp structure. How generally valid this observation may be needs further investigation. The findings may open new possibilities for diagnosis and treatment of urinary tract infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997213     DOI: 10.1007/bf01639597

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  28 in total

1.  Investigating ligand-receptor interactions at bilayer surface using electronic absorption spectroscopy and fluorescence resonance energy transfer.

Authors:  Navneet Dogra; Xuelian Li; Punit Kohli
Journal:  Langmuir       Date:  2012-07-16       Impact factor: 3.882

Review 2.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

3.  Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins.

Authors:  J Parkkinen; R Virkola; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

4.  Binding characteristics of Escherichia coli adhesins in human urinary bladder.

Authors:  R Virkola; B Westerlund; H Holthöfer; J Parkkinen; M Kekomäki; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

Review 5.  P-fimbriae, bacterial adhesion, and pyelonephritis.

Authors:  J Winberg
Journal:  Arch Dis Child       Date:  1984-02       Impact factor: 3.791

6.  Nucleotide sequence of the papA gene encoding the Pap pilus subunit of human uropathogenic Escherichia coli.

Authors:  M Båga; S Normark; J Hardy; P O'Hanley; D Lark; O Olsson; G Schoolnik; S Falkow
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

7.  Occurrence of P-fimbriated Escherichia coli in patients with bacteremia.

Authors:  A Brauner; M Leissner; B Wretlind; I Julander; S B Svenson; G Källenius
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

8.  Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test.

Authors:  S B Svenson; G Källenius; R Möllby; H Hultberg; J Winberg
Journal:  Infection       Date:  1982       Impact factor: 3.553

9.  P-antigen-recognizing fimbriae from human uropathogenic Escherichia coli strains.

Authors:  T K Korhonen; V Väisänen; H Saxén; H Hultberg; S B Svenson
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia.

Authors:  Sara N Smith; Erin C Hagan; M Chelsea Lane; Harry L T Mobley
Journal:  mBio       Date:  2010-11-23       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.